Diversity of multinucleated giant cells by microstructures of hydroxyapatite and plasma components in extraskeletal implantation model
Source abstract
Abstract
Unlabelled Foreign body giant cells (FBGCs) and osteoclasts are multinucleated giant cells (MNGCs), both of which are formed by the fusion of macrophage-derived mononuclear cells. Osteoclasts are distinct from FBGCs due to their bone resorption ability; however, not only morphological, but also functional similarities may exist between these cells. The characterization and diversity of FBGCs that appear in an in vivo foreign body reaction currently remain incomplete. In the present study, we investigated an in vivo foreign body reaction using an extraskeletal implantation model of hydroxyapatite (HA) with different microstructures. The implantation of HA granules in rat subcutaneous tissue induced a foreign body reaction that was accompanied by various MNGCs. HA granules composed of rod-shaped particles predominantly induced cathepsin K (CTSK)-positive FBGCs, whereas HA granules composed of globular-shaped particles predominantly induced CTSK-negative FBGCs. Plasma, which was used as the binder of ceramic granules, stimulated the induction of CTSK-positive FBGCs more strongly than purified fibrin. Furthermore, the implantation of HA composed of rod-shaped particles with plasma induced tartrate-resistant acid phosphatase (TRAP)-positive MNGCs in contrast to HA composed of globular-shaped particles with purified fibrin, which predominantly induced CTSK-negative and TRAP-negative typical FBGCs. These results suggest that CTSK-positive, TRAP-positive, and CTSK- and TRAP-negative MNGCs are induced in this subcutaneous implantation model in a manner that is dependent on the microstructure of HA and presence or absence of plasma. Statement of significance We attempted to elucidate the mechanisms responsible for the foreign body reaction induced by the implantation of hydroxyapatite granules with different microstructures in rat subcutaneous tissue with or without plasma components as the binder of ceramic granules. By analyzing the expression of two reliable osteoclast markers, we detected tartrate-resistant acid phosphatase-positive multinucleated giant cells, cathepsin K-positive multinucleated giant cells, and tartrate-resistant acid phosphatase- and cathepsin K-negative multinucleated giant cells. The induction of tartrate-resistant acid phosphatase-positive multinucleated giant cells was plasma component-dependent while the induction of cathepsin K-positive multinucleated giant cells was influenced by the microstructure of hydroxyapatite. This is the first study to show the conditions dividing the three kinds of multinucleated giant cells in the foreign body reaction.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bone Metabolism and Diseases · Bone Tissue Engineering Materials · Bone health and osteoporosis research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (41)
Show source-provided references
1. Giant cell formation and function10.1097/MOH.0b013e32831ac52e ↗
2. The cell biology of osteoclast function10.1242/jcs.113.3.377 ↗
3. Identification of matrix metalloproteinase 9 in rabbit osteoclasts10.1016/S0021-9258(17)36566-3 ↗
4. Molecular cloning of a possible cysteine proteinase predominantly expressed in osteoclasts10.1016/S0021-9258(17)42227-7 ↗
5. Matrix metalloproteinases and bone10.1016/j.bone.2008.03.020 ↗
6. Polarized osteoclasts put marks of tartrate-resistant acid phosphatase on dentin slices – a simple method for identifying polarized osteoclasts10.1016/j.bone.2011.09.045 ↗
7. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation10.1016/S0092-8674(00)81569-X ↗
8. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL10.1073/pnas.95.7.3597 ↗
9. New insights into osteoclastogenic signaling mechanisms10.1016/j.tem.2012.05.005 ↗
10. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts10.1016/S1534-5807(02)00369-6 ↗
11. Autoamplification of NFATc1 expression determines its essential role in bone homeostasis10.1084/jem.20051150 ↗
12. DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells10.1084/jem.20050645 ↗
13. Osteoclast stimulatory transmembrane protein and dendritic cell-specific transmembrane protein cooperatively modulate cell-cell fusion to form osteoclasts and foreign body giant cells10.1002/jbmr.1575 ↗
14. Foreign body-type multinucleated giant cells induced by interleukin-4 express select lymphocyte co-stimulatory molecules and are phenotypically distinct from osteoclasts and dendritic cells10.1016/j.yexmp.2011.06.012 ↗
15. Foreign body reaction to biomaterials10.1016/j.smim.2007.11.004 ↗
16. Molecular mediators of macrophage fusion10.1016/j.tcb.2009.07.005 ↗
17. Interleukin-4 induces foreign body giant cells from human monocytes/macrophages. Differential lymphokine regulation of macrophage fusion leads to morphological variants of multinucleated giant cells
18. Interleukin-13 induces human monocyte/macrophage fusion and macrophage mannose receptor expression10.4049/jimmunol.158.7.3385 ↗
19. Interleukin-1 receptor-associated kinase-4 (IRAK4) promotes inflammatory osteolysis by activating osteoclasts and inhibiting formation of foreign body giant cells10.1074/jbc.M114.568360 ↗
20. Interleukin-4 reversibly inhibits osteoclastogenesis via inhibition of NF-kappa B and mitogen-activated protein kinase signaling10.1074/jbc.M104957200 ↗
21. IL-4 abrogates osteoclastogenesis through STAT6-dependent inhibition of NF-kappaB10.1172/JCI10530 ↗
22. GM-CSF and IL-4 induce dendritic cell differentiation and disrupt osteoclastogenesis through M-CSF receptor shedding by up-regulation of TNF-alpha converting enzyme (TACE)10.1182/blood-2009-04-215020 ↗
23. Interleukin-4 and interleukin-13 stimulate the osteoclast inhibitor osteoprotegerin by human endothelial cells through the STAT6 pathway10.1359/jbmr.080203 ↗
24. Hydrothermal preparation of tailrod hyrdoxyapatite10.1007/s10853-006-7338-5 ↗
25. Hydrothermal synthesis of biocompatible whiskers10.1007/BF00352039 ↗
26. Stimulatory effect of hydrothermally synthesized biodegradable hydroxyapatite granules on osteogenesis and direct association with osteoclasts10.1016/j.biomaterials.2009.05.002 ↗
27. The slow resorption with replacement by bone of a hydrothermally synthesized pure calcium-deficient hydroxyapatite10.1016/j.biomaterials.2008.03.028 ↗
28. The effect of the microstructure of beta-tricalcium phosphate on the metabolism of subsequently formed bone tissue10.1016/j.biomaterials.2007.01.040 ↗
29. Osteoclast resorption of beta-tricalcium phosphate controlled by surface architecture10.1016/j.biomaterials.2014.05.048 ↗
30. Phenotypic expression in human monocyte-derived interleukin-4-induced foreign body giant cells and macrophages in vitro: dependence on material surface properties10.1002/jbm.a.35280 ↗
31. Lineage-committed osteoclast precursors circulate in blood and settle down into bone10.1002/jbmr.490 ↗
32. Cathepsin K – a marker of macrophage differentiation?10.1002/path.959 ↗
33. Foreign body giant cells and osteoclasts are TRAP positive, have podosome-belts and both require OC-STAMP for cell fusion10.1002/jcb.24518 ↗
34. Expression of cathepsin K and tartrate-resistant acid phosphatase is not confined to osteoclasts but is a general feature of multinucleated giant cells: systematic analysis10.1093/rheumatology/ket184 ↗
35. The foreign body giant cell cannot resorb bone, but dissolves hydroxyapatite like osteoclasts10.1371/journal.pone.0139564 ↗
36. A bone substitute with high affinity for vitamin D-binding protein-relationship with niche of osteoclasts10.1111/jcmm.12180 ↗
37. Promotion of normal healing of bone defects under estrogen deficiency by implantation of beta-tricalcium phosphate composed of rod-shaped particles10.1002/jor.22514 ↗
38. Is marginal bone loss around oral implants the result of a provoked foreign body reaction?10.1111/cid.12142 ↗
39. Foreign body reaction to biomaterials: on mechanisms for buildup and breakdown of osseointegration10.1111/cid.12274 ↗
40. Macrophage responses to implants: prospects for personalized medicine10.1189/jlb.5VMR0415-166R ↗
41. Identification of cell cycle-arrested quiescent osteoclast precursors in vivo10.1083/jcb.200806139 ↗